PDF(1057 KB)
Efficacy and safety of lactase additive in preterm infants with lactose intolerance: a prospective randomized controlled trial
WANG Li, WANG Yi-Wen, TAN Jin-Tong, YAN Jie, WU Yan, WANG Xin-Meng, YANG Wen-Zhi, QIAN Ji-Hong
Chinese Journal of Contemporary Pediatrics ›› 2021, Vol. 23 ›› Issue (7) : 671-676.
PDF(1057 KB)
PDF(1057 KB)
Efficacy and safety of lactase additive in preterm infants with lactose intolerance: a prospective randomized controlled trial
Objective To study the efficacy and safety of lactase additive in improving lactose intolerance in preterm infants. Methods A total of 60 preterm infants with lactose intolerance who were admitted to the Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from January 2018 to December 2019 were randomly divided into a lactase treatment group and a control group, with 30 infants in each group. The infants in the lactase treatment group were given 4 drops of lactase additive (180 mg) added into preterm formula or breast milk, and those in the control group were given placebo, oral administration of probiotics (live combined Bifidobacterium, Lactobacillus and Enterococcus powder) at half an hour after feeding (1 g each time, twice a day), and clockwise abdominal massage around the belly button at 1 hour after feeding for 15 minutes each time, 3 times a day. Fecal pH, fecal reducing sugar, growth indicators, symptoms of lactose intolerance, and laboratory markers were measured at the end of the first and second weeks after intervention. Results Finally 29 infants in the lactase treatment group and 26 infants in the control group completed the trial. At the end of the first week after intervention, compared with the control group, the lactase treatment group had significantly lower frequency of daily milk vomiting and gastric retention amount (P < 0.05) and a significantly higher proportion of infants with fecal pH > 5.0 (P < 0.05). At the end of the second week after intervention, compared with the control group, the lactase treatment group had significantly lower frequency of daily milk vomiting and 24-hour abdominal circumference difference (P < 0.05) and a significantly higher proportion of infants with the absence of gastric retention, fecal pH > 5.0, or negative reducing sugar in feces (P < 0.05). No adverse reactions associated with the lactase additive or probiotics were observed during the trial. Conclusions Lactase additive can safely and effectively improve the clinical symptoms caused by lactose intolerance in preterm infants.
[1] Heine RG, AlRefaee F, Bachina P, et al. Lactose intolerance and gastrointestinal cow's milk allergy in infants and children-common misconceptions revisited[J]. World Allergy Organ J, 2017, 10(1):41. DOI:10.1186/s40413-017-0173-0. PMID:29270244. PMCID:PMC5726035.
[2] Szilagyi A, Ishayek N. Lactose intolerance, dairy avoidance, and treatment options[J]. Nutrients, 2018, 10(12):1994. DOI:10.3390/nu10121994. PMID:30558337. PMC6316316.
[3] 郑直, 虞人杰. 早期新生儿乳糖吸收不良与乳糖不耐受筛查及影响因素探讨[J]. 新生儿科杂志, 2003, 18(6):244-246. DOI:10.3969/j.issn.1673-6710.2003.06.002.
[4] 叶环, 饶燕晓, 徐琛, 等. 住院新生儿乳糖酶缺乏及其体格生长的随访研究[J]. 发育医学电子杂志, 2019, 7(2):115-120. DOI:10.3969/j.issn.2095-5340.2019.02.008.
[5] 中国医师协会新生儿科医师分会循证专业委员会. 新生儿坏死性小肠结肠炎临床诊疗指南(2020)[J]. 中国当代儿科杂志, 2021, 23(1):1-11. DOI:DOI:10.7499/j.issn.1008-8830.2011145. PMID:33476530. PMCID:PMC7818154.
[6] 苏慧敏, 姜毅, 胡玉莲, 等. 新生儿非感染性腹泻乳糖不耐受发生情况调查[J]. 中国当代儿科杂志, 2016, 18(4):306-310. DOI:10.7499/j.issn.1008-8830.2016.04.005. PMID:27097573. PMCID:PMC7390084.
[7] Silberman ES, Jin J. Lactose intolerance[J]. JAMA, 2019, 322(16):1620. DOI:10.1001/jama.2019.9608. PMID:31638683.
[8] Shulman RJ, Wong WW, Smith EO. Influence of changes in lactase activity and small-intestinal mucosal growth on lactose digestion and absorption in preterm infants[J]. Am J Clin Nutr, 2005, 81(2):472-479. DOI:10.1093/ajcn.81.2.472. PMID:15699237.
[9] Heyman MB, Committee on Nutrition. Lactose intolerance in infants, children, and adolescents[J]. Pediatrics, 2006, 118(3):1279-1286. DOI:10.1542/peds.2006-1721. PMID:16951027.
[10] Vandenplas Y. Lactose intolerance[J]. Asia Pac J Clin Nutr, 2015, 24(Suppl 1):S9-S13. DOI:10.6133/apjcn.2015.24.s1.02. PMID:26715083.
[11] Griffin MP, Hansen JW. Can the elimination of lactose from formula improve feeding tolerance in premature infants?[J]. J Pediatr, 1999, 135(5):587-592. DOI:10.1016/s0022-3476(99)70057-0. PMID:10547247.
[12] Szajewska H. Extensive and partial protein hydrolysate preterm formulas[J]. J Pediatr Gastroenterol Nutr, 2007, 45(Suppl 3):S183-S187. DOI:10.1097/01.mpg.0000302969.60373.39. PMID:18185089.
[13] 余慕雪, 庄思齐, 王丹华, 等. 深度水解蛋白配方乳对早产儿喂养和生长影响的多中心临床对照研究[J]. 中国当代儿科杂志, 2014, 16(7):684-690. DOI:10.7499/j.issn.1008-8830.2014.07.006. PMID:25008873.
[14] 侯德红, 张琳, 丁雪晶, 等. 深度水解蛋白配方奶对早产低体重儿喂养疗效观察[J]. 中国实用儿科杂志, 2014, 29(11):874-876. DOI:10.7504/ek2014110618.
[15] Misselwitz B, Butter M, Verbeke K, et al. Update on lactose malabsorption and intolerance:pathogenesis, diagnosis and clinical management[J]. Gut, 2019, 68(11):2080-2091. DOI:10.1136/gutjnl-2019-318404. PMID:31427404. PMCID:PMC6839734.
[16] Erasmus HD, Ludwig-Auser HM, Paterson PG, et al. Enhanced weight gain in preterm infants receiving lactase-treated feeds:a randomized, double-blind, controlled trial[J]. J Pediatr, 2002, 141(4):532-537. DOI:10.1067/mpd.2002.127499. PMID:12378193.
[17] 石壮, 翁志媛, 张又祥. 添加乳糖酶与无乳糖奶粉喂养治疗婴幼儿乳糖不耐受的效果对比[J]. 中国当代医药, 2019, 26(14):104-107. DOI:10.3969/j.issn.1674-4721.2019.14.031.
[18] Pereira-da-Silva L, Dias MP, Virella D, et al. Osmolality of preterm formulas supplemented with nonprotein energy supplements[J]. Eur J Clin Nutr, 2008, 62(2):274-278. DOI:10.1038/sj.ejcn.1602736. PMID:17375112.
[19] Ugidos-Rodríguez S, Matallana-González MC, Sánchez-Mata MC. Lactose malabsorption and intolerance:a review[J]. Food Funct, 2018, 9(8):4056-4068. DOI:10.1039/c8fo00555a. PMID:29999504.
[20] Hodges JK, Cao SS, Cladis DP, et al. Lactose intolerance and bone health:the challenge of ensuring adequate calcium intake[J]. Nutrients, 2019, 11(4):718. DOI:10.3390/nu11040718. PMID:30925689. PMCID:PMC6521087.
